|
|
||||||||
Musculoskeletal Imaging |
1 From the Department of Radiology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224-3899 (M.J.K., L.W.B., J.J.P.); Department of Radiologic Pathology, Armed Forces Institute of Pathology, Walter Reed Army Medical Center, Washington, DC (M.J.K., M.D.M.); Department of Radiology and Nuclear Medicine, Uniformed Services University of the Health Sciences, Bethesda, Md (M.D.M.); Department of Radiology, University of Maryland School of Medicine, Baltimore (M.D.M.); Department of Orthopedic Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond (W.C.F.); and Department of Orthopedics and Rehabilitation, University of Miami School of Medicine, Fla (H.T.T.). Received June 26, 2001; revision requested August 16; final revision received January 4, 2002; accepted January 23. Address correspondence to M.J.K. (e-mail: kransdorf.mark@mayo .edu).
| ABSTRACT |
|---|
|
|
|---|
MATERIALS AND METHODS: CT (n= 29) and MR (n = 40) images and radiographs (n = 28) of 60 patients with histologically verified fatty tumors (35 lipomas and 25 well-differentiated liposarcomas) were retrospectively reviewed in 31 females and 29 males (mean age, 56 years; age range, 1-88 years). Images were assessed for adipose tissue content, and nonfatty component was classified (thin and/or thick septa and nodular and/or globular components) as absent, mild, moderate, or pronounced. Also assessed were signal intensity and tissue attenuation of the fatty components and nonadipose elements.
RESULTS: Statistically significant imaging features favoring a diagnosis of liposarcoma included lesion larger than 10 cm (P < .001), presence of thick septa (P = .001), presence of globular and/or nodular nonadipose areas (P = .003) or masses (P = .001), and lesion less than 75% fat (P < .001). The most statistically significant radiologic predictors of malignancy were male sex, presence of thick septa, and associated nonadipose masses, which increased the likelihood of malignancy by 13-, nine-, and 32-fold, respectively. Both lipoma and liposarcoma demonstrated thin septa and regions of increased signal intensity on fluid-sensitive MR images.
CONCLUSION: A significant number of lipomas will have prominent nonadipose areas and will demonstrate an imaging appearance traditionally ascribed to well-differentiated liposarcoma. Features that suggest malignancy include increased patient age, large lesion size, presence of thick septa, presence of nodular and/or globular or nonadipose masslike areas, and decreased percentage of fat composition.
© RSNA, 2002
Index terms: Lipoma and lipomatosis, 40.363 Lipoma and lipomatosis, CT, 40.1211 Lipoma and lipomatosis, MR, 40.1214 Liposarcoma, 40.371 Liposarcoma, CT, 40.1211 Liposarcoma, MR, 40.1214 Soft tissues, neoplasms, 40.363, 40.371
| INTRODUCTION |
|---|
|
|
|---|
Lipoma is a benign mesenchymal tumor in which the lesion closely resembles normal fat. The resemblance is so great that the fat within a lipoma cannot be distinguished histologically from normal fat; however, there are biochemical and ultrastructural differences (1). Well-differentiated liposarcomas also resemble lipomas, although they tend to be larger, are often traversed by dense bands of collagen, have gelatinous areas, and have adipocytes that show greater variation in size than an ordinary lipoma (1). Additionally, well-differentiated liposarcomas contain enlarged adipocytes, atypical hyperchromatic cells with angular nuclei, and lipoblasts (1).
As there are histologic similarities between lipoma and well-differentiated liposarcoma, there are also considerable imaging similarities. The purpose of our study was to review the reliability of CT and MR imaging features in distinguishing lipoma and well-differentiated liposarcoma.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Images reviewed included CT scans (in 29 patients; 15 with contrast material enhancement), MR images (in 40 patients, eight with contrast enhancement), and radiographs (in 28 patients). Radiologic features assessed included lesion size (greatest dimension) and location, presence or absence of intralesional calcification, and percentage of lesion appearing similar to host adipose tissue. A lesion was considered completely composed of adipose tissue if it demonstrated a signal intensity and character identical to that of the subcutaneous adipose tissue. The percentage of fat was graded from 0 to 4 as follows: 0 = 100% fat, 1 = 90%99% fat, 2 = 75%90% fat, 3 = 50%75% fat, and 4 = 50% fat or less. Additionally, the presence and character of the nonadipose components of the lesion were categorized. The number and character of septa, globular and/or nodular areas, and associated masses were recorded. Septa were considered thin if they were uniform and no thicker than 2 mm. Those thicker than 2 mm or those that had focal thickening were considered thick. More irregular conglomerate areas were considered globular and/or nodular. These features were also quantified as absent, mild, moderate, or pronounced. The designation of mass was reserved for dominant focal nonadipose soft-tissue masses within the lesion, and the size of the mass was recorded. To ensure the greatest consistency in evaluation of imaging features, images were assessed by the senior author following determination of the grading criteria by means of consensus. Patient age and sex were also recorded, as was complaint at presentation. The presence and amount of "altered" fat was assessed. Altered fat was defined as lesional adipose tissue that demonstrated a poorly defined, slightly increased attenuation at CT or nonspecific signal intensity at MR imaging. Finally, the extent (none, mild, moderate, or intense) and character (homogeneous, heterogeous, or linear and/or septal) of gadolinium-based enhancement was evaluated.
Patient demographics and lesion location were compared by using the Wilcoxon rank sum test for continuous variables and the
2 test for categorized variables. A multiple logistic regression model was built by using a stepwise selection method to assess which study variables best predicted patients with liposarcoma. Data analysis was performed with SAS software (SAS Institute, Cary, NC). A P value of .05 was considered to indicate a statistically significant difference.
Excised specimens were not available for review or for mapping correlation with images. Pathologic reports were reviewed for descriptive comments characterizing the nonadipose areas of the tumors.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contrast-enhanced MR images were available in eight patients (four with lipomas and four with liposarcomas). One lipoma showed no enhancement, and three showed mild linear enhancement. The four liposarcomas showed mild to moderate enhancement (Fig 4). The presence or absence of calcification was determined only at review of radiographs and CT images and was assessed in 46 patients (27 with lipomas and 19 with liposarcomas). Calcification was three times more likely to occur in liposarcoma, being identified in six (32%) liposarcomas and three (11%) lipomas.
| DISCUSSION |
|---|
|
|
|---|
In the current review, we have documented a wider spectrum of imaging features of lipoma than has been previously appreciated, to our knowledge, and we have identified causes of these imaging features. We have identified several statistically significant features to help distinguish lipoma from liposarcoma in most cases and have provided the odds ratios for these features. The most important of these features are the presence of thickened septa, nodular and/or globular areas of nonadipose tissue within the lesion, associated nonadipose masses, and a total amount of nonadipose tissue composing more than 25% of the lesion.
The appearances of well-defined malignancies reviewed in the present study are similar to those reported previously (510)slightly heterogeneous lipomatous masses, resembling lipoma, with nonadipose septal and swirled and/or irregular nodular areas with nonspecific signal intensities. Contrast enhancement of the nonadipose areas has been described as faint (10). Hosono et al (8) noted that the septal structures in liposarcoma were thick, had irregular widths, and had marked enhancement on fat-suppressed T1-weighted images following gadopentetate dimeglumine administration. In contradistinction, they found septa in lipoma to be thin with faint enhancement, suggesting that this pattern might be useful in distinguishing lipoma and liposarcoma. Although only a small number of patients were imaged with gadolinium-based enhancement, our results were relatively similar.
In contrast to liposarcoma, lipoma has been characterized as showing homogeneous fatty attenuation at CT and a homogeneous signal intensity identical to that of fat in all pulse sequences at MR imaging (7,11). In the current study, all four lesions that were composed completely of fat (identical in appearance to subcutaneous adipose tissue at imaging) were lipomas. To date, this is the most reliable feature in establishing the diagnosis of lipoma at imaging. Thin fibrous septa of low signal intensity on T1- and T2-weighted images may traverse the lesion, as may intermingled muscle (9,11,12). Lipomas may show varying marginsMatsumoto et al (11) identified well-defined margins in 12 of 17 patients with intramuscular lipomas and infiltrating margins in the remaining five.
In the present study, 11 (31%) of 35 lipomas showed marked nonadipose areas. The imaging features in these cases could not be mapped to the excised specimens; however, review of surgical and pathologic reports showed that they correlated with fat necrosis and associated calcification, fibrosis, inflammation, and myxoid change. Mature fat is subject to a variety of superimposed secondary inflammatory processes (13). These include not only lipase-induced fat necrosis, but also various forms of panniculitis or lipogranuloma formation that may form tumorlike masses (13). In the present study, masslike areas were present in two lipomas and suggested dedifferentiation. Although fat necrosis is well described in subcutaneous tissue, there are limited reports on fat necrosis in lipomatous tumors (14). We suspect that the high prevalence of these changes in our study likely reflect a referral bias, in that large lipomas or lesions with atypical imaging features are more likely to be excised and histologic findings referred for consultation. Well-differentiated liposarcoma has traditionally been separated radiologically from other subtypes of liposarcoma by means of the percentage of adipose tissue within the lesion. Well-differentiated liposarcoma is typically composed of more than 75% fat, while other histologic subtypes usually have less than 25% fat (15). Eleven (44%) of 25 liposarcomas and three (9%) of 35 lipomas in our study had less than 75% fat. This also likely reflects a referral bias.
In our review, benign lesions were significantly smaller than malignancies (P = .001), a relationship that has been shown previously in multiple studies (11,16). Patients with lipoma were also significantly younger than those with liposarcoma (P = .011), as previously reported (12).
Calcification was seen in six (24%) malignant and three (9%) benign lesions. Calcification was reported in three (23%) of 13 lipomas reported by Chew and Hudson (17), with no calcification identified in any of five liposarcomas. The benign calcifications in that report were associated with fat necrosis. Our experience would suggest that although calcification is not specific, it is seen with a greater prevalence in malignant lesions.
In summary, lipoma can be successfully distinguished from well-differentiated liposarcoma when it is completely composed of adipose tissue. A significant number of lipomas will have prominent nonadipose areas and demonstrate an imaging appearance traditionally ascribed to well-differentiated liposarcoma. Imaging features that suggest malignancy include increased patient age, large lesion size, presence of thick septa, presence of nodular and/or globular or nonadipose masslike areas, and decreased percentage of fat composition.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Pathology Quiz Case 2: Diagnosis Arch Otolaryngol Head Neck Surg, September 1, 2008; 134(9): 1014 - 1015. [Full Text] [PDF] |
||||
![]() |
H. Sakurai, M. Kaji, K. Yamazaki, and K. Suemasu Intrathoracic lipomas: their clinicopathological behaviors are not as straightforward as expected. Ann. Thorac. Surg., July 1, 2008; 86(1): 261 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Chakraborty, E E Kassel, and E Yu Nasopharyngeal liposarcoma MRI imaging features and a review of the literature Br. J. Radiol., July 1, 2007; 80(955): e145 - e146. [Abstract] [Full Text] [PDF] |
||||
![]() |
P O'Sullivan, H O'Dwyer, J Flint, P L Munk, and N Muller Soft tissue tumours and mass-like lesions of the chest wall: a pictorial review of CT and MR findings Br. J. Radiol., July 1, 2007; 80(955): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
I-C Chiang, M-Y Jang, K-B Tsai, and T-J Hsieh Huge renal lipoma with prominent hypervascular non-adipose elements. Br. J. Radiol., October 1, 2006; 79(946): e148 - e151. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hoshi, S. Matsumoto, J. Manabe, T. Tanizawa, T. Shigemitsu, H. Koyanagi, K. Ae, K. Takeuchi, and N. Kawaguchi Surgery for dedifferentiated liposarcoma, presenting two radiologically and pathologically distinctive patterns. Jpn. J. Clin. Oncol., July 1, 2006; 36(7): 462 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Murphey, L. K. Arcara, and J. Fanburg-Smith From the Archives of the AFIP: Imaging of Musculoskeletal Liposarcoma with Radiologic-Pathologic Correlation RadioGraphics, September 1, 2005; 25(5): 1371 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Zamora, C. A. Zamora, E. A. Samayoa, H. A. Morales, and J. F. Ceballos High-Resolution Ultrasonography in an Aggressive Thenar Intramuscular Lipoma J. Ultrasound Med., August 1, 2005; 24(8): 1151 - 1155. [Full Text] [PDF] |
||||
![]() |
D. A. Torigian and E. S. Siegelman CT Findings of Pelvic Lipomatosis of Nerve Am. J. Roentgenol., March 1, 2005; 184(3_supp): S94 - S96. [Full Text] [PDF] |
||||
![]() |
A. Lopez Soriano, A. Tomasello, P. Luburich, and A. Noel Fat Necrosis in a Chest Wall Lipoma Am. J. Roentgenol., September 1, 2004; 183(3): 866 - 866. [Full Text] [PDF] |
||||
![]() |
M. D. Murphey, J. F. Carroll, D. J. Flemming, T. L. Pope, F. H. Gannon, and M. J. Kransdorf From the Archives of the AFIP: Benign Musculoskeletal Lipomatous Lesions RadioGraphics, September 1, 2004; 24(5): 1433 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. O'Connor, L. B. Dixon, T. Peabody, and G. S. Stacy MRI of Cystic and Soft-Tissue Masses of the Shoulder Joint Am. J. Roentgenol., July 1, 2004; 183(1): 39 - 47. [Full Text] [PDF] |
||||
![]() |
C. M. Gaskin and C. A. Helms Lipomas, Lipoma Variants, and Well-Differentiated Liposarcomas (Atypical Lipomas): Results of MRI Evaluations of 126 Consecutive Fatty Masses Am. J. Roentgenol., March 1, 2004; 182(3): 733 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Chan, R. Gee, C. Keogh, and P. L. Munk Imaging Features of Fat Necrosis Am. J. Roentgenol., October 1, 2003; 181(4): 955 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohguri, T. Aoki, M. Hisaoka, H. Watanabe, K. Nakamura, H. Hashimoto, T. Nakamura, and H. Nakata Differential Diagnosis of Benign Peripheral Lipoma from Well-Differentiated Liposarcoma on MR Imaging: Is Comparison of Margins and Internal Characteristics Useful? Am. J. Roentgenol., June 1, 2003; 180(6): 1689 - 1694. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |